A test of concordance between patient and psychiatrist valuations of multiple treatment goals for schizophrenia

Health Expectations

Volumn 16, Issue 2, 2013, Pages 164-176

  Bridges, John F P ^a   Slawik, Lara ^b   Schmeding, Annette ^b   Reimer, Jens ^c   Naber, Dieter ^c   Kuhnigk, Olaf ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JANSSEN CILAG GMBH   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Doctor patient concordance; Outcomes research; Patient preferences; Patient centred care; Schizophrenia; Self explicated method

Indexed keywords

ADOLESCENT; ADULT; COMPARATIVE STUDY; FEMALE; HUMAN; INFORMATION PROCESSING; INTERVIEW; MALE; MIDDLE AGED; MOTIVATION; PSYCHIATRY; PSYCHOLOGY; SCHIZOPHRENIA; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; YOUNG ADULT; ARTICLE; STATISTICS;

ADOLESCENT; ADULT; FEMALE; FOCUS GROUPS; GOALS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PSYCHIATRY; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84877657150     PISSN: 13696513     EISSN: 13697625     Source Type: Journal    
DOI: 10.1111/j.1369-7625.2011.00704.x     Document Type: Article

References (58)

1. concordance, n. Oxford English Dictionary, 2nd edn, 1989; online version November 2010. Avialable at: http://www.oed.com:80/Entry/38351, accessed 19 December 2010. Earlier version first published in New English Dictionary, 1891
2. Royal Pharmaceutical Society of Great Britain. From Compliance to Concordance: Towards Shared Goals in Medicine Taking. London: RPS, 1997.
3. Mullen PD. Compliance becomes concordance: making a change in terminology produce a change in behaviour. BMJ, 1997; 314: 691.
4. Rogers W. Evidence-based medicine in practice: limiting or facilitating patient choice?Health Expectations, 2002; 5: 95-103.
5. Bajramovic J, Emmerton L, Tett SE. Perceptions around concordance - focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. Health Expectations, 2004; 7: 221-234.
6. Knapp P, Raynor DK, Thistlethwaite JE, Jones MB. A questionnaire to measure health practitioners' attitudes to partnership in medicine taking: LATCon II. Health Expectations, 2009; 12: 175-186.
7. Steven K, Marsden W, Neville RG, Hoskins G, Sullivan FM, Drummond N. Do the British guidelines for asthma management facilitate concordance?Health Expectations, 2004; 7: 74-84.
8. Stevenson FA, Cox K, Britten N, Dundar Y. A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expectations, 2004; 7: 235-245.
9. Liaw ST, Young D, Farish S. Improving patient-doctor concordance: an intervention study in general practice. Family Practice, 1996; 13: 427-431.
10. Sonn GA, Sadetsky N, Presti JC, Litwin MS. Differing perceptions of quality of life in patients with prostate cancer and their doctors. Journal of Urology, 2009; 182: 2296-2302.
11. Coulter A. Paternalism or partnership. British Medical Journal, 1999; 319: 719-720.
12. Kinter E, Schmeding A, Rudolph I, dosReis S, Bridges J. Identifying patient-relevant endpoints among individuals with schizophrenia: an application of patient centered health technology assessment. International Journal of Technology Assessment in Health Care, 2009; 25: 35-41.
13. Bridges J, Cohen JP, Grist PG, Mühlbacher AC. International experience with comparative effectiveness research: case studies from England/Wales and Germany. Advances in Health Economics and Health Services Research, 2010; 22: 29-50.
14. Caro J, Nord E, Siebert U et al. The efficiency frontier approach to economic evaluation of health-care interventions. Health Economics, 2010; 19: 1117-1127.
15. Scarsini M. On measures of concordance. Stochastica, 1994; 8: 201-218.
16. Spearman C. The proof and measurement of association between two things. The American Journal of Psychology, 1904; 15: 72-101.
17. Kendall MG. Rank Correlation Methods. New York: Hafner Publishing Company, 1955.
18. Goulet F, Jacques A, Gagnon R, Racette P, Sieber W. Assessment of family physicians' performance using patient charts: interrater reliability and concordance with chart-stimulated recall interview. Evaluation and the Health Professions, 2007; 30: 376-392.
19. Eckert J, Schaaf R. Verfahren zur Praferenzmessung - Eine Ubersicht und Beurteilung existierender und moglicher neuer Self-Explicated-Verfahren. Journal fur Betriebswirtschaft, 2009; 59: 31-56.
20. Green PE, Srinivasan V. Conjoint analysis in marketing: new developments with implication for research and practice. Journal of Marketing, 1990; 54: 3-19.
21. Thornicroft G, Tansella M, Becker T. The personal impact of schizophrenia in Europe. Schizophrenia Research, 2004; 69: 125-132.
22. Naber D, Karow A, Lambert M. Psychosocial outcomes in patients with schizophrenia: quality of life and reintegration. Current Opinions in Psychiatry, 2002; 15: 31-36.
23. Priebe S. Social outcomes in schizophrenia. The British Journal of Psychiatry. Supplement, 2007; 191 (Suppl. 50): S15-S20.
24. Heinz A, Naber D, Juckel G. Outcomeparameter in der Schizophrenietherapie. Mehr als nur Linderung der Symptomatik. Neurotransmitter, 2006; 11: 51-56.
25. Bobes J, Ciudad A, Alvarez E, San L, Polavieja P, Gilaberte I. Recovery from schizophrenia: results from a 1-year follow-up observational study of patients in symptomatic remission. Schizophrenia Research, 2009; 115: 58-66.
26. Leucht S, Heres S. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. Journal of Clinical Psychiatry, 2006; 67 (Suppl. 5): 3-8.
27. Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN) (ed.). S3 Praxisleitlinien in Psychiatrie und Psychotherapie. Band 1 Behandlungsleitlinie Schizophrenie. Darmstadt: DGPPN, 2006.
28. NIMH. The National Institute of Mental Health Strategic Plan. Washington, DC: National Institute of Mental Health, 2008. Available at: http://www.nimh.nih.gov/about/strategic-planning-reports/nimh-strategic-plan-2008.pdf.
29. Kikkert MJ, Schene AH, Koeter MW et al. Medication adherence in schizophrenia: exploring Patients', Carers' and Professionals' views. Schizophrenia Bulletin, 2006; 32: 786-794.
30. Shumway M, Saunders T, Shern D et al. Preferences for schizophrenia treatment outcomes among public policy makers, consumers, families, and providers. Psychiatric Services, 2003; 54: 1124-1128.
31. Shumway M. Preferences weights for cost-outcome analyses of schizophrenia treatments: comparison of four stakeholder groups. Schizophrenia Bulletin, 2003; 29: 257-266.
32. Fisher EP, Shumway M, Owen RR. Priorities of consumers, providers, and family members in the treatment of schizophrenia. Psychiatric Services, 2002; 53: 724-729.
33. Naber N, Karow A. Good tolerability equals good results: the patient′s perspective. European Neuropsychopharmacology, 2001; 11 (Suppl. 4): 391-396.
34. Hamann J, Leucht S, Kissling W. Shared decision making in psychiatry. Acta Psychiatrica Scandinavia, 2003; 107: 403-409.
35. Glickman SW, Peterson ED. Innovative health reform models: pay-for-performance initiatives. The American Journal of Managed Care, 2009; 15 (Suppl.): S300-S305.
36. Scheibler F, von Pritzbuer E, Pfaff H. Shared decision-making: Ein Überblicksartikel über die internationale Forschungsliteratur. Sozial- und Präventivmedizin [Social and Preventive Medicine (in English)], 2003; 48: 11-23.
37. Hamann J, Cohen R, Leucht S, Busch R, Kissling W. Shared decision-making and long-term outcome in schizophrenia treatment. Journal of Clinical Psychiatry, 2007; 68: 992-997.
38. Vogt F, Schwappach D, Bridges FP. Accounting for tastes. A German perspective on the inclusion of patient preferences in healthcare. Pharmaoeconomics, 2006; 24: 419-423.
39. Angermeyer MC, Holzinger A, Kilian R, Matschinger H. Quality of life - as defined by schizophrenic patients and psychiatrists. International Journal of Social Psychiatry, 2001; 47: 34-42.
40. Hufnagel E, Locklear J, Caruso R, Doyle J, Diamond R. Treatment goal expectations of physicians and patients with schizophrenia. Atlanta, Georgia: American Psychiatric Association 56th Institute on Psychiatric Services, 2004. Poster session 2, number 65.
41. Rosenheck R, Stroup S, Keefe R et al. Measuring outcome priorities and preferences in people with schizophrenia. British Journal of Psychiatry, 2005; 187: 529-536.
42. Bridges J, Kinter E, Schmeding A, Rudolph I, Mühlbacher I. Can patients with schizophrenia complete choice-based conjoint analysis tasks?The Patient: Patient-Centered Outcomes Research, 2011; in press.
43. Atkinson M, Zibin S, Chuang H. Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology. American Journal of Psychiatry, 1997; 154: 99-105.
44. Revicki DA, Shakespeare A, Kind P. Preferences for schizophrenia-related health states: a comparison of patients, caregivers and psychiatrists. International Clinical Psychopharmacology, 1996; 11: 101-108.
45. Heres S, Schmitz FS, Leucht S, Pajonk FG. The attitudes of patients towards antipsychotic depot treatment. International Clinical Psychopharmacology, 2007; 22: 275-282.
46. Bridges J, Kinter E, Kidane L, Heinzen R, McCormick C. Things are looking up since we started listening to patients: recent trends in the application of conjoint analysis in health 1970-2007. The Patient - Patient Centered Outcomes Research, 2008; 1: 273-282.
47. Marshall D, Bridges J, Hauber AB et al. Conjoint analysis applications in health - how are studies being designed and reported? An update on current practice in the published literature between 2005 and 2008. The Patient - Patient Centered Outcomes Research, 2010; 3: 249-256.
48. Chen K, Ali M, Veeman M, Unterschultz J, Le T. Relative importance rankings for pork attributes by Asian-Origin Consumers in California: applying an ordered probit model to a choice-based sample. Journal of Agricultural and Applied Economics, 2002; 34: 67-79.
49. Biesma RG, Pavlova M, van Merode GG, Groot W. Using conjoint analysis to estimate employers preferences for key competencies of master level Dutch graduates entering the public health field. Economics of Education Review, 2007; 26: 375-386.
50. Pavlova M, Groot W, van Merode G. The importance of quality, access and price to health care consumers in Bulgaria: a self-explicated approach. The International Journal of Health Planning and Management, 2003; 18: 343-361.
51. National Institute of Standards and Technology. Comparing multiple proportions: the Marascuilo procedure. Available at: http://www.itl.nist.gov/div898/handbook/prc/section4/prc474.htm, accessed 20 April 2010.
52. Fraenkel L. Conjoint analysis at the individual patient level: issues to consider as we move from a research to a clinical tool. The Patient - Patient Centered Outcomes Research, 2008; 1: 251-253.
53. Gardner DM, MacKinnon N, Langille DB, Andreou P. A comparison of factors used by physicians and patients in the selection of antidepressant agents. Psychiatric Services, 2007; 58: 34-40.
54. Cunningham CE, Deal K, Rimas H et al. Using conjoint analysis to model the preferences of different patient segments for attributes of patient-centered care. The Patient: Patient-Centered Outcomes Research, 2008; 1: 317-330.
55. Bridges J. Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics. Applied Health Economics and Health Policy, 2003; 2: 213-224.
56. Pereira C, Mulligan M, Bridges J, Bishai D. Determinants of influenza vaccine purchasing decision in the US: a conjoint analysis. Vaccine, 2011; 29: 1443-1447.
57. Nathan H, Bridges J, Schulick RD et al. Understanding surgical decision-making in early hepatocellular carcinoma. Journal of Clinical Oncology, 2011; 29: 619-625.
58. Bridges J, Selck F, Gray G, McIntyre J, Martinson N. Condom avoidance and determinants of demand for male circumcision in Johannesburg, South Africa. Health Policy and Planning, 2010; doi:10.1093/heapol/czq064.